{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:40:04Z","timestamp":1787017204592,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1136\/ijgc-2024-005323","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T09:00:31Z","timestamp":1722934831000},"page":"101849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0584-0810","authenticated-orcid":false,"given":"Masahiro","family":"Aichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-0643","authenticated-orcid":false,"given":"Sho","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ishidera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-0844","authenticated-orcid":false,"given":"Etsuko","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005323_bib1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/ijc.34002","article-title":"Ovarian cancer today and tomorrow: a global assessment by world region and human development index using GLOBOCAN 2020","volume":"151","author":"Cabasag","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2024-005323_bib2","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005323_bib3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Mirvetuximab soravtansine in FR\u03b1-positive, platinum-resistant ovarian cancer","volume":"389","author":"Moore","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2024-005323_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.2007.13.6606","article-title":"Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer","volume":"26","author":"Ferrandina","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"'Platinum resistant' ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2019.05.029","article-title":"Development and validation of a prognostic nomogram for overall survival in patients with platinum- resistant ovarian cancer treated with chemotherapy","volume":"117","author":"Lee","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005323_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mlc.2001.113504","article-title":"Sarcopenia","volume":"137","author":"Morley","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1136\/ijgc-2024-005323_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"key":"10.1136\/ijgc-2024-005323_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pan.2018.11.001","article-title":"Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy","volume":"19","author":"Kurita","year":"2019","journal-title":"Pancreatology"},{"key":"10.1136\/ijgc-2024-005323_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111966","article-title":"Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy","volume":"109","author":"Aichi","year":"2023","journal-title":"Nutrition"},{"key":"10.1136\/ijgc-2024-005323_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in advanced serous ovarian cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005323_bib13","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3346\/jkms.2021.36.e2","article-title":"Sarcopenia as a predictor of prognosis in early stage ovarian cancer","volume":"36","author":"Chae","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1136\/ijgc-2024-005323_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcsm.12468","article-title":"Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis","volume":"10","author":"Ubachs","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1136\/ijgc-2024-005323_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12957-020-01981-x","article-title":"Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: a retrospective study","volume":"18","author":"Sakamoto","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10147-020-01805-8","article-title":"Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib","volume":"26","author":"Murachi","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1136\/ijgc-2024-005323_bib18","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"10.1136\/ijgc-2024-005323_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annonc.2019.10.020","article-title":"Inconsistencies in currently used definitions of sarcopenia in oncology","volume":"31","author":"Taguchi","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta- analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1136\/ijgc-2024-005323_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jcsm.12946","article-title":"Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population","volume":"13","author":"Moon","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1136\/ijgc-2024-005323_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcsm.12885","article-title":"Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients","volume":"13","author":"Ubachs","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1136\/ijgc-2024-005323_bib24","series-title":"A language and environment for statistical computing","author":"Team","year":"2013"},{"key":"10.1136\/ijgc-2024-005323_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","article-title":"Inflammation and sarcopenia: a systematic review and meta-analysis","volume":"96","author":"Bano","year":"2017","journal-title":"Maturitas"},{"key":"10.1136\/ijgc-2024-005323_bib26","article-title":"Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study","volume":"3","author":"Feliciano","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1136\/ijgc-2024-005323_bib28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s12094-019-02080-4","article-title":"Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib","volume":"21","author":"G\u00f6kyer","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1136\/ijgc-2024-005323_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.58","article-title":"Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients","volume":"108","author":"Huillard","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2024-005323_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/SLA.0000000000002679","article-title":"Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis","volume":"268","author":"Simonsen","year":"2018","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2024-005323_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1136\/ijgc-2024-005323_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clnu.2011.05.008","article-title":"Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food","volume":"30","author":"Deutz","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1136\/ijgc-2024-005323_bib33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.47102\/annals-acadmedsg.2022158","article-title":"Low skeletal muscle mass predicts poor prognosis of elderly patients after emergency laparotomy: a single Asian institution experience","volume":"51","author":"Tan","year":"2022","journal-title":"Ann Acad Med Singap"},{"key":"10.1136\/ijgc-2024-005323_bib34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1017\/S0007114508207221","article-title":"Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults","volume":"102","author":"Rush","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1136\/ijgc-2024-005323_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1136\/ijgc-2024-005323_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25009685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25009685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:10:40Z","timestamp":1767996640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25009685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1048891X25009685"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005323","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"101849"}}